Addressing quality-of-life challenges for patients with end-stage metastatic castrate-resistant prostate cancer.
APA
Jang A, Grier AL, Barata PC (2025). Addressing quality-of-life challenges for patients with end-stage metastatic castrate-resistant prostate cancer.. The oncologist, 30(9). https://doi.org/10.1093/oncolo/oyaf253
MLA
Jang A, et al.. "Addressing quality-of-life challenges for patients with end-stage metastatic castrate-resistant prostate cancer.." The oncologist, vol. 30, no. 9, 2025.
PMID
41014154
같은 제1저자의 인용 많은 논문 (3)
- EXTRA-PC: a phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancer.
- Serum thyroglobulin testing after thyroid lobectomy in patients with 1-4 cm papillary thyroid carcinoma.
- Prognosis of Patients with 1-4 cm Papillary Thyroid Cancer Who Underwent Lobectomy: Focus on Gross Extrathyroidal Extension Invading Only the Strap Muscles.